CASI Pharmaceuticals, Inc. (CASIF)

Name: CASI Pharmaceuticals, Inc. (CASIF) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001962738 · OTC · Pharmaceutical Preparations

Sector Manufacturing
Fiscal year ends Dec 31

For the year ended 2025-12-31, CASI Pharmaceuticals, Inc. reported revenue of $20.71M. Revenue fell 27.4% from the prior annual period.

Key ratios (year ended 2025-12-31)

48.6%

Gross margin

-217.3%

Operating margin

-232.0%

Net margin

-27.4%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 6-K (current report) · 2026-09-02

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Revenue	$20.71M	$28.54M	$33.88M	$43.11M	$30.17M	$15.14M
Cost of Revenue	$10.64M	$17.39M	$13.83M	$15.83M	$12.56M	$9.51M
Gross Profit	$10.08M	$11.15M	$20.05M	$27.28M	$17.61M	$5.63M
R&D Expense	$6.31M	$8.92M	$9.86M	$16.00M	$14.42M	$11.47M
Operating Income	-$45.01M	-$39.62M	-$25.08M	-$34.03M	-$41.52M	-$52.78M
Depreciation & Amortization	$1.20M	$1.30M	$2.50M	$1.20M	$500.0K	$600.0K
EBITDA	-$43.81M	-$38.32M	-$22.58M	-$32.83M	-$41.02M	-$52.18M
Net Income	-$48.06M	-$39.26M	-$26.96M	-$41.01M	-$36.65M	-$48.29M
EPS (Diluted)	-$2.59	-$2.56	-$2.02	-$3.01	-$2.69	-$4.37
Total Assets	$25.65M	$53.67M	$75.27M	$96.23M	$138.30M	n/a
Total Liabilities	$62.93M	$51.82M	$51.10M	$29.30M	$30.34M	n/a
Shareholders' Equity	-$37.28M	$1.85M	$24.16M	$44.57M	$84.50M	$81.54M
Cash & Equivalents	$5.63M	$13.47M	$17.08M	$47.11M	$38.70M	n/a
Operating Cash Flow	-$20.75M	-$29.22M	-$19.97M	-$21.09M	-$26.84M	-$25.89M
Capital Expenditures	$16.0K	$223.0K	$204.0K	$5.61M	$8.95M	$1.50M
Free Cash Flow	-$20.77M	-$29.45M	-$20.17M	-$26.70M	-$35.79M	-$27.39M
Share Repurchases	n/a	n/a	$278.0K	$3.27M	n/a	n/a
Shares Outstanding	20.56M	15.49M	13.38M	13.46M	13.98M	n/a
Weighted Average Diluted Shares	18.54M	15.34M	13.36M	13.65M	13.61M	11.05M
EPS (Basic)	-$2.59	-$2.56	-$2.02	-$3.01	-$2.69	-$4.37